Study claims obese people take more sick days off work Roshni Dhar15 May 2024 3:39 PM ISTResearchers from Vienna, studying over 122,000 individuals across Europe, have highlighted the significant impact of obesity on work absenteeism,...
Medical Bulletin 15/ May/ 2024 Anshika Mishra15 May 2024 3:00 PM ISTHere are the top medical news for the day:Commonly used antibiotics associated with increased complications- JAMA studyAccording to a study published...
Health Bulletin 14/ May/ 2024 Roshni Dhar14 May 2024 5:07 PM ISTHere are the top health news for the day:NEET candidates paid up to Rs 50 lakhs for getting question papers in advanceThe brokers involved in the NEET...
Flagship Pioneering, Metaphore Biotechnologies partner Novo Nordisk to develop next-Generation Therapeutics for Obesity Management Ruchika Sharma12 May 2024 12:15 PM ISTCambridge: Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and...
Conduct Active Post Marketing Surveillance Study: CDSCO Panel tells Novo Nordisk on Somapacitan Injection Dr. Divya Colin28 April 2024 6:00 PM ISTNew Delhi: Granting approval for waiving off the Phase-IV study, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novo Nordisk to acquire Cardior Pharma for up to 1.025 billion Euros Ruchika Sharma27 March 2024 1:30 PM ISTDenmark Novo Nordisk and Cardior Pharmaceuticals have announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...
Novo Nordisk Awiqli recommended for approval for diabetes by European regulatory authorities Ruchika Sharma23 March 2024 2:12 PM ISTAwiqli is a once-weekly basal insulin analogue designed to cover the basal insulin requirements for a full week with a single subcutaneous injection.
Novo Nordisk hopes to launch weight loss pill Amycretin this decade Ruchika Sharma11 March 2024 12:50 PM ISTNovo's current plan is to advance the development of amycretin in its oral and injectable form simultaneously, and it gives a regulatory advantage to...
Working with several countries authorities to tackle counterfeit versions of Ozempic: Novo Nordisk CEO Ruchika Sharma10 March 2024 12:15 PM ISTDenmark: Novo Nordisk's CEO on Friday said the company was working with authorities in several countries to tackle counterfeit versions of its popular...
Novo Nordisk Wegovy gets USFDA nod for lowering heart risks Ruchika Sharma9 March 2024 2:30 PM ISTDenmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a...
Cipla, Dr Reddys and other Indian Pharma companies now in race to develop Wegovy versions Ruchika Sharma22 Feb 2024 2:27 PM IST"Dr Reddy's and Cipla are making a copy of the innovator drug more like a generic version, while Sun is working on its own innovator drug. So, Sun...
Novo Nordisk parent invests in India's Manipal hospital chain Ruchika Sharma7 Feb 2024 3:45 PM ISTStockholm: Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Tuesday it was investing in Indian private...
